anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
IHC Assay
IVD
For in vitro diagnostic use.
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
PRAME (PReferentially expressed Antigen in MElanoma) is a tumor biomarker expressed in most cutaneous and ocular melanomas as well as various other malignant neoplasms.1
PRAME expression in formalin-fixed paraffin-embedded tissue is detected by immunohistochemistry and frequently demonstrates a diffuse nuclear immunostaining pattern in in situ and invasive melanoma. In contrast, the majority of benign melanocytic nevi lack nuclear PRAME staining.2
Studies suggest that detection of PRAME expression by immunohistochemistry (IHC) may complement findings from routinely used H&E and other IHC panels and aid in:
- Differential diagnoses of benign versus malignant melanocytic lesions1,2
- Evaluation of tumor margins in melanoma specimens1,2
- Evaluation of sentinel lymph nodes in melanoma cases.3
The power of PRAME: A pathlogists perspective
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Melanoma: A survivor story
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
References
- Lezcano, C. et al. PRAME expression in melanocytic tumors. Am J Surg Pathol 2018;42(11):1456-1465.
- Lezcano, C. et al. PRAME immunohistochemistry as an ancillary test for the assessment of melanocytic lesions. Surg Pathol Clin 2021 Jun;14(2):165-175.
- Lezcano, C. et al. Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma. Am J Surg Pathol 2020;44(4):503-508.
Description
Documents techniques
Accéder aux documents disponibles dans votre pays
Vous êtes actuellement sur le site Web mondial. Modifiez la localisation pour afficher les options de langues ou accédez à eLabDoc, le référentiel des documents des produits.
